Sol-Gel Technologies Ltd.: Clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Current pipeline leverages proprietary technology platform. Two P3 readouts in 2019: Rosacea (Epsolay) mid-year; Acne (TWIN) year-end.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Listing
Public, USA
Market Cap
100MM - 500MM
Website:
Address:
Sol-Gel Technologies Ltd
7 Golda Meir St.
NESS-ZIONA, State/Province 7403650
Israel

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Solebury Trout Clients at Jefferies

New York, NY, United States, June 4 – June 7, 2019

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2017 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.